South Africa, Eswatini and Zambia have launched the first public distribution of lenacapavir, a revolutionary HIV-prevention injection shown to reduce transmission risk by over 99.9 percent. The rollout, supported by global health agencies and aimed at regions with the worlds highest HIV infection rate, marks a major step forward in HIV prevention, even as advocates urge broader access and lower pricing.
Recommended For You
Disclaimer: We are a news aggregator. See full disclaimer here.